Pregnancy-related complications such as gestational hypertension (GH), preeclampsia (PE), HELLP (Hemolysis, Elevated Liver enzymes and Low Platelets) syndrome, fetal growth restriction (FGR), small for gestational age (SGA), gestational diabetes mellitus (GDM), preterm birth (spontaneous preterm birth or preterm premature rupture of membranes), and pregnancy loss (late miscarriage and stillbirth) induce long-term metabolic and vascular abnormalities that might increase the overall risk of metabolic, cardiovascular, cerebrovascular, kidney, and other diseases later in life in mothers and their offspring.

This special issue aims to provide an overview of the latest research on the mechanisms, diagnostic and/or prognostic modalities, and treatment strategies associated with pregnancy-related complications leading to the consequent development of metabolic and cardiovascular abnormalities (hypertension, dyslipidaemia, hyperglycaemia, obesity, echocardiography (ECHO) and electrocardiogram (ECG) abnormalities, endothelial dysfunction, etc.) and to the consequent onset of metabolic, cardiovascular, and cerebrovascular diseases (diabetes mellitus, myocardial infarction, cerebral infarction, systolic or diastolic heart failure, pulmonary arterial hypertension, etc.).

This comprehensive special issue will be of interest not only to scientists but also to physicians from different complementary disciplines such as gynecology and obstetrics, cardiology, preventive medicine, general medicine, neonatology, and paediatrics. Just the interconnection of various expertises may bring benefits to our patients and significantly improve the physical health of a broader population.

Keywords: Gestational hypertension, preeclampsia, HELLP syndrome, fetal growth restriction, gestational diabetes mellitus, preterm birth, pregnancy loss, cardiovascular risk, cardiovascular disease, cerebrovascular disease